What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary

Detalles Bibliográficos
Autores principales: Iolascon, Giovanni, Moretti, Antimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2022
Materias:
Cochrane Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919666/
https://www.ncbi.nlm.nih.gov/pubmed/35234153
_version_ 1784668980554760192
author Iolascon, Giovanni
Moretti, Antimo
author_facet Iolascon, Giovanni
Moretti, Antimo
author_sort Iolascon, Giovanni
collection PubMed
description
format Online
Article
Text
id pubmed-8919666
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Musculoskeletal and Neuronal Interactions
record_format MEDLINE/PubMed
spelling pubmed-89196662022-04-14 What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary Iolascon, Giovanni Moretti, Antimo J Musculoskelet Neuronal Interact Cochrane Corner International Society of Musculoskeletal and Neuronal Interactions 2022 /pmc/articles/PMC8919666/ /pubmed/35234153 Text en Copyright: © Journal of Musculoskeletal and Neuronal Interactions https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cochrane Corner
Iolascon, Giovanni
Moretti, Antimo
What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary
title What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary
title_full What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary
title_fullStr What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary
title_full_unstemmed What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary
title_short What are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D? - A Cochrane Review summary with commentary
title_sort what are the efficacy and safety of pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5d? - a cochrane review summary with commentary
topic Cochrane Corner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919666/
https://www.ncbi.nlm.nih.gov/pubmed/35234153
work_keys_str_mv AT iolascongiovanni whataretheefficacyandsafetyofpharmacologicalinterventionsversusplacebonotreatmentorusualcareforosteoporosisinpeoplewithchronickidneydiseasestages35dacochranereviewsummarywithcommentary
AT morettiantimo whataretheefficacyandsafetyofpharmacologicalinterventionsversusplacebonotreatmentorusualcareforosteoporosisinpeoplewithchronickidneydiseasestages35dacochranereviewsummarywithcommentary

Ejemplares similares